IBO
AMEX · Pharmaceuticals
Impact Biomedical Inc
$0.48
-0.02 (-3.80%)
Open$0.49
Previous Close$0.50
Day High$0.52
Day Low$0.44
52W High$1.95
52W Low$0.36
Volume—
Avg Volume99.1K
Market Cap54.15M
P/E Ratio—
EPS$-1.26
SectorPharmaceuticals
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 107.8K | 2.01M | 2.09M |
| Net Income | -40,454,526 | 252.5K | 255.6K |
| Profit Margin | -36,993.8% | 12.5% | 12.2% |
| EBITDA | -10,717,430 | 413.4K | 402.4K |
| Free Cash Flow | — | 302.8K | 206.2K |
| Rev Growth | — | +12.9% | +6.5% |
| Debt/Equity | 0.05 | 0.52 | 0.58 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,124.85 | +0.68% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $245.14 | +1.72% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $124.71 | +3.41% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $23.83 | -0.87% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.00 | -0.95% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $77.65 | -0.67% | 12.5 | 33.00B |